JMBA
ABBV icon

J. M. Brown & Associates’s AbbVie ABBV Stock Holding History

J. M. Brown & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Buy
+3,242
New +$698K 0.47% 66

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

J. M. Brown & Associates's ABBV Position: Q2 2026 in Review

J. M. Brown & Associates opened a new position in AbbVie (ABBV) in Q2 2026: 3,242 shares worth $816K. The stake represents 0.47% of the portfolio and ranks #66 among its holdings.

4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • J. M. Brown & Associates held 3,242 shares of AbbVie worth $816K as of Q2 2026.
  • AbbVie was a new J. M. Brown & Associates position in Q2 2026.
  • AbbVie made up 0.47% of J. M. Brown & Associates's portfolio in Q2 2026, its #66 holding.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J. M. Brown & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.